Dabucon, Nereka M.
HRN: 25-35-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/26/2024
10/03/2024
IV
500MG
Q8H
ACUTE APPENDICITIS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes